PHASE II PILOT STUDYOF VELCADE® (BORTEZOMIB) IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Kong, Xiao-Tang [1 ]
Green, Stacey [1 ]
Filka, Emese [1 ]
Green, Richard [2 ]
Yong, William [1 ]
Nghiemphu, Phioanh [1 ]
Cloughesy, Timothy [1 ]
Lai, Albert [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Kaiser Permanente Los Angeles, Los Angeles, CA USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY EVALUATION OF A PHASE II STUDY OF BORTEZOMIB IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Kong, Xiao-Tang
    Nguyen, Nhung
    Choi, Yoon
    Zhang, Guicheng
    Nguyen, Huytram
    Filka, Emese
    Green, Stacy
    Yong, William
    Liau, Linda
    Kaprealian, Tania
    Pope, Whitney
    Nghiemphu, Phioanh
    Cloughesy, Timothy
    Lassman, Andrew
    Lai, Albert
    NEURO-ONCOLOGY, 2017, 19 : 12 - 12
  • [2] UPDATED RESULTS OF PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Lai, Albert
    Nghiemphu, Phioanh
    Green, Richard M.
    Spier, Liz
    Peak, Scott
    Phuphanich, Surasak
    Fehrenbacher, Lou
    Kolevska, Tatjana
    Polikoff, Jonathan A.
    Cloughesy, Timothy F.
    NEURO-ONCOLOGY, 2009, 11 (05) : 632 - 632
  • [3] Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment
    Kong, Xiao-Tang
    Nguyen, Nhung T.
    Choi, Yoon J.
    Zhang, Guicheng
    Nguyen, HuyTram N.
    Filka, Emese
    Green, Stacey
    Yong, William H.
    Liau, Linda M.
    Green, Richard M.
    Kaprealian, Tania
    Pope, Whitney B.
    Nghiemphu, P. Leia
    Cloughesy, Timothy
    Lassman, Andrew
    Lai, Albert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1195 - 1203
  • [4] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly-diagnosed glioblastoma multiforme.
    Brewer, CJ
    Suh, JH
    Stevens, GHJ
    Barnett, GH
    Toms, S
    Vogelbaum, MA
    Weil, R
    Peereboom, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 130S - 130S
  • [5] Phase II trial of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme
    Lai, A.
    Nghiemphu, P.
    Green, R.
    Spier, L.
    Peak, S.
    Phuphanich, S.
    Fehrenbacher, L.
    Kolevska, T.
    Polikoff, J.
    Cloughesy, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
    Chang, SM
    Lamborn, KR
    Malec, M
    Larson, D
    Wara, W
    Sneed, P
    Rabbitt, J
    Page, M
    Nicholas, MK
    Prados, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 353 - 357
  • [7] Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: Interim analysis of safety and tolerability
    Lai, Albert
    Filka, Emese
    McGibbon, Bruce
    Nghiemphu, Phioanh Leia
    Graham, Carrie
    Yong, William H.
    Mischel, Paul
    Liau, Linda M.
    Bergsneider, Marvin
    Pope, Whitney
    Selch, Michael
    Cloughesy, Tim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05): : 1372 - 1380
  • [8] Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment (vol 100, pg 1195, 2018)
    Kong, X-T
    Nguyen, N. T.
    Choi, Y. J.
    Lassman, Andrew B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1289 - 1289
  • [9] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [10] PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ranjan, Tulika
    Desjardins, Annick
    Peters, Katherine B.
    Alderson, Lloyd
    Kirkpatrick, John
    Herndon, James, II
    Bailey, Leighann
    Sampson, John
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2012, 14 : 79 - 79
12345